Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Insulet Corp
(NQ:
PODD
)
163.58
-1.15 (-0.70%)
Streaming Delayed Price
Updated: 2:53 PM EDT, Apr 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
340,651
Open
165.29
Bid (Size)
163.50 (2)
Ask (Size)
163.65 (1)
Prev. Close
164.73
Today's Range
162.11 - 167.10
52wk Range
125.82 - 335.91
Shares Outstanding
68,873,869
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Weight-Loss ETFs to Profit From the Obesity Drug Boom
April 17, 2024
Leverage Oprah's shift to prescription weight solutions with Weight-Loss ETFs, targeting companies leading in obesity treatment.
Via
InvestorPlace
Topics
ETFs
7 Stable Stocks for 50% Returns by Early 2025
April 15, 2024
These 7 stable stocks also offer 50% returns according to analysts according to analysts tasked with following their respective industries.
Via
InvestorPlace
Performance
YTD
-21.77%
-21.77%
1 Month
-4.12%
-4.12%
3 Month
-19.78%
-19.78%
6 Month
+12.63%
+12.63%
1 Year
-49.84%
-49.84%
More News
Read More
Why NASDAQ:PODD Is a Promising High-Growth Stock in the Midst of Consolidation.
April 05, 2024
Via
Chartmill
Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024
April 03, 2024
From
Insulet Corporation
Via
Business Wire
Analyst Scoreboard: 5 Ratings For Insulet
February 23, 2024
Via
Benzinga
Insulet: Q4 Earnings Insights
February 22, 2024
Via
Benzinga
Should you consider NASDAQ:PODD for growth investing?
February 01, 2024
Via
Chartmill
Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers Over The Past 12 Months
March 31, 2024
Via
Talk Markets
5 Stocks To Buy On The Dip To Gain From The Wall Street Rally
March 23, 2024
Via
Talk Markets
Insulet Appoints Ana Maria Chadwick as Chief Financial Officer
March 20, 2024
From
Insulet Corporation
Via
Business Wire
Why NASDAQ:PODD Is a Promising High-Growth Stock in the Midst of Consolidation.
March 14, 2024
Via
Chartmill
Are These 5 Undervalued Stocks Ready to Break Out?
March 08, 2024
Via
MarketBeat
Insulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy
March 08, 2024
From
Insulet Corporation
Via
Business Wire
Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
March 05, 2024
From
Insulet Corporation
Via
Business Wire
Is It Time to Buy the S&P 500's 3 Worst-Performing February Stocks?
March 04, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Top Stocks Not Named Nvidia You Need To Know About In 2024: Here's What Investors Think About Them (Wall Street Vs. Reddit)
February 29, 2024
Via
Benzinga
Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday
February 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
DexCom: A Winner In Diabetes Management
February 25, 2024
Via
Talk Markets
Nasdaq, S&P 500 Set for Mixed Open After Nvidia Euphoria: Analyst Picks Major Market Catalyst This Year If There Are No Rate Cuts
February 23, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's After-Market Session
February 22, 2024
Via
Benzinga
Insulet Reports Full Year 2023 Revenue Increase of 30% (30% Constant Currency1) and Fourth Quarter 2023 Revenue Increase of 38% Year-Over-Year (37% Constant Currency)
February 22, 2024
From
Insulet Corporation
Via
Business Wire
Nasdaq, S&P 500 Futures Jump As Nvidia Surge Raises 'FOMO' Rally Hopes: Analyst Tells Why Jobs Data Holds Key For Momentum
February 22, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference
February 13, 2024
From
Insulet Corporation
Via
Business Wire
Earnings Scheduled For February 22, 2024
February 22, 2024
Via
Benzinga
Insulet Announces CE Mark Approval of Omnipod® 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor
February 07, 2024
From
Insulet Corporation
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.